Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Search Results for 

Sort by date 130 pages found matching Glaxo

  • Trail of Paxil Suicides Leads To GlaxoSmithKline
    Feb-14-07 Washington, DC: On January 29, 2007, BBC-One broadcast, "Secrets of the Drug Trials," a Panorama program based on an investigation by reporter, Shelley Jofre, which revealed how GlaxoSmithKline misled doctors into prescribing Paxil off-label to children, even after its own clinical trials found that kids could become suicidal when taking the drug. The...
  • GlaxoSmithKline Defamed With Truth About Paxil
    Jan-31-07 London, UK: GlaxoSmithKline has labeled the allegations made in a Panorama television program that said the company had suppressed the results of clinical trials that showed Paxil was ineffective and caused children to become suicidal "defamatory." According to the January 30, 2007, Guardian, an official at the company said Glaxo had looked into takin...
  • Glaxo Writing Checks Left and Right to Settle Paxil Legal Battles
    Dec-3-06 Madison County, IL: GlaxoSmithKline is no doubt looking forward to the New Year because the end of this one is becoming costlier by the month. On November 1, 2006, the Associated Press reported that Glaxo had agreed to pay $63.8 million to settle a class action lawsuit with allegations that Glaxo promoted Paxil for use with children and adolescents wh...
  • Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part I)
    Feb-12-08 Washington, DC GlaxoSmithKline recently received greetings from a Congressional Committee, asking the company to explain the findings in a report unsealed last month in a lawsuit which shows that Glaxo knew as early as 1989 that Paxil increased the risk of suicidal behavior in patients by more than 8-fold compared to patients who received a placebo. In...
  • Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part II)
    Feb-13-08 Washington, DC Apparently, GlaxoSmithKline is still trying to hide damaging information about Paxil, because 9 pages of a report released from under a court order last month, are not available to the public. However, Senator Charles Grassley has instructed Glaxo to provide him with the full report by February 14, 2008. In the report, which is dated roug...
  • Drip Drip Drip - Paxil Info Leaks Out
    Apr-25-06 Secrecy agreements in litigation hide information about defective products or a company's negligence, and sometimes go so far as to prohibit the parties from discussing that there ever was a lawsuit. Such is the case with Paxil and as a result, unwitting patients continued to take the drug long after its dangers were known to GlaxoSmithKline. Many lawsuit...
  • Avandia Heart Attack Risk, Questions Remain
    May-25-09 Washington, DC Today is a milestone for GlaxoSmithKline's Avandia. According to various sources it was May 25, 1999 that Avandia received regulatory approval for the treatment of Type 2 diabetes. However, much has happened in the ten years since Avandia first surfaced with so much promise: various studies and other analyses pointing to heart attack and v...
  • Lawsuits Against Glaxo Rise as Avandia Sales Plummet
    Aug-1-07 Washington, DC: A study released in July 2007, by the Federal Agency for Health Care Research and Quality, reported that the older diabetes drugs, available for as little as $10 a month, are as safe and effective as the newer drugs like Avandia (rosiglitazone), which costs between $131 and $262 a month. On July 20, 2007, Science Daily reported that li...
  • SSRI Antidepressants Pushers
    Nov-16-08 After twenty long years, it appears that the epidemic in mental disorders in America might be coming to an end. It won't happen because of any great medical breakthrough but rather because the perpetrators of the greatest healthcare fraud in history are finally being exposed. The demolition of the giant "psycho-pharmaceutical complex" appears to be on the ho...
  • Glaxo now faces Lawsuit by Shareholders over Avandia Problems
    Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of...
  • Glaxo Stuck in Damage Control Mode Over Avandia
    Jun-4-07 Washington, DC: On May 23, 2007, the Associated Press reported that more than 6 million people worldwide have taken Avandia (rosiglitazone), made by GlaxoSmithKline, to control blood sugar since it came on the market in 1999, and about 1 million patients in the US currently use the drug. However, studies recently analyzed at the Cleveland Clinic shows A...
  • Zantac Patent, GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute
    New York, NY: (Jan-28-08) Drug developer Cypress Pharmaceutical Inc. had been locked in a patent infringement lawsuit with a unit of British drug maker GlaxoSmithKline PLC related to a generic version of Glaxo's Zantac syrup to treat symptoms of heartburn. Sources close to the case stated that privately held Cypress Pharma said Glaxo agreed not to assert i...
  • Paxil Birth Defect Cases Continue on the Road to Settlement
    Jun-29-10 Washington, DC Expectant mothers who suffer from depression face a difficult decision: Paxil and other antidepressants have been linked to an increased risk of birth defects, yet many pregnant women are unable to manage their depression without medication. While the debate rages on over the best course of action, it seems that the US Food and Drug Admi...
  • Glaxo $750 Million Settlement Fourth-Largest in History
    Oct-28-10 Boston, MA A whistleblower is $96 million richer after bringing a federal False Claims Act (FCA) lawsuit against UK pharmaceutical giant GlaxoSmithKline (Glaxo) over deviations in good manufacturing practices at a former plant in Puerto Rico. In total, Glaxo agreed to pay $750 million in penalties and will plead guilty to a criminal charge in rela...
  • Average Paxil Birth Defect Settlement $1.2 Million
    Aug-28-10 London, UK While no amount of money can adequately compensate for a life-altering birth defect allegedly caused by or linked to the use of the antidepressant Paxil, the average settlement in a Paxil birth defect lawsuit appears to be in excess of $1.2 million for each family involved. The Newark Star-Ledger noted in July that Paxil manufacturer GlaxoSm...
  • Lawyer Accuses Drug Company of Ignoring Paxil Risks
    Sep-18-09 Philadelphia, PA GlaxoSmithKline ignored evidence about Paxil birth defects, according to a lawyer involved in a lawsuit regarding Paxil heart defects. The lawyer told the jury that Glaxo told scientists to avoid making public the risks of Paxil defects when the antidepressant was used by pregnant women. According to an article in The Philadelphia...
  • Glaxo Profits Anemic, Avandia Partly to Blame
    Feb-23-09 Washington, DC It might be the largest pharmaceutical manufacturer in Europe, but GlaxoSmithKline (Glaxo) is in the midst of a restructuring, with job cuts on the horizon. While it has been reported there are many factors behind those struggles, the ongoing debate over the safety and efficacy of Avandia—in concert with recent black box warnings for hear...
  • Sheldon Bradshaw - Bush Administration Preemption Gang
    Mar-4-08 Washington, DC: Sheldon Bradshaw stepped in to replace the pharmaceutical industry's inside guy, Daniel Troy, in the Office of Chief Counsel at the FDA in April 2005, and the Bush Administration's steadfast protection of the industry did not miss a beat. On September 20, 2005, an article by Lily Henning entitled, "Is FDA's New Chief Counsel a Change in...
  • Jury Trials in 2008 Expected to Expose SSRI Maker's Dirty Secrets
    Jan-23-08 Washington, DC: The blockbuster sales figures for the new generation of selective serotonin reuptake inhibitor antidepressants ( SSRI 's), which have resulted from their promotion for so many unapproved uses, represents the most profitable off-label marketing coup in the history of modern medicine. Sales total about $21 billion a year, according to IMS Hea...
  • Glaxo gets Hit with another Paxil Birth Defects Lawsuit
    Oct-17-06 Denver, CO Two years ago, little Eric Jackson was born with persistent pulmonary hypertension, a life-threatening lung disorder in which an infant's arteries to the lungs remain constricted after birth, limiting the amount of blood flow to the lungs and oxygen in the bloodstream. Persistent pulmonary hypertension (PPHN) is associated with substantial in...
Page: 1  2  3  4  5  6  7     Next»



Request Legal Help Now! - Free